Last 12 months
Inside the activity.
1 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2023 Filed Mar 6, 2023 21:48 UTC |
Vadaketh Tom GeorgeEVP, Chief Financial Officer
|
Tax withholdingCommon Shares, No Par Value | 4,001 | $9.25 | $37,009.25 |
DisclosureSEC source: 0001127602-23-009095 · form4.xml · nonDerivative · entry 1 Vadaketh Tom George · CIK 0001694891 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,203 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:47 UTC |
Barresi John SSVP, Controller & CAO
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 21,812 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001127602-23-009094 · form4.xml · derivative · entry 2 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,812 Underlying: Common Shares, No Par Value · 21,812 shares Expires 2033-03-02 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:47 UTC |
Barresi John SSVP, Controller & CAO
|
GrantCommon Shares, No Par Value | 25,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009094 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,037 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:45 UTC |
Carson SeanaEVP, General Counsel
|
SaleCommon Shares, No Par Value | 292 | $9.32 | $2,721.44 |
DisclosureSEC source: 0001127602-23-007989 · form4.xml · nonDerivative · entry 3 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,185 F3 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:45 UTC |
Carson SeanaEVP, General Counsel
|
Tax withholdingCommon Shares, No Par Value | 768 | $9.57 | $7,349.76 |
DisclosureSEC source: 0001127602-23-007989 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,477 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:45 UTC |
Carson SeanaEVP, General Counsel
|
Tax withholdingCommon Shares, No Par Value | 1,474 | $9.57 | $14,106.18 |
DisclosureSEC source: 0001127602-23-007989 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,245 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:43 UTC |
APPIO THOMASDirector · Chief Executive Officer
|
Tax withholdingCommon Shares, No Par Value | 2,069 | $9.57 | $19,800.33 |
DisclosureSEC source: 0001127602-23-007985 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,573 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:43 UTC |
APPIO THOMASDirector · Chief Executive Officer
|
Tax withholdingCommon Shares, No Par Value | 4,258 | $9.57 | $40,749.06 |
DisclosureSEC source: 0001127602-23-007985 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,642 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 21:36 UTC |
Vadaketh Tom GeorgeEVP, Chief Financial Officer
|
Tax withholdingCommon Shares, No Par Value | 6,310 | $6.28 | $39,626.80 |
DisclosureSEC source: 0001127602-23-000519 · form4.xml · nonDerivative · entry 1 Vadaketh Tom George · CIK 0001694891 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,204 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:04 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 9,952 | $6.28 | $62,498.56 |
DisclosureSEC source: 0001127602-23-000168 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,290 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:11 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 5,186 | $6.28 | $32,568.08 |
DisclosureSEC source: 0001127602-23-000171 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,765 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:08 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 4,589 | $6.28 | $28,818.92 |
DisclosureSEC source: 0001127602-23-000170 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,190 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:07 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 4,589 | $6.28 | $28,818.92 |
DisclosureSEC source: 0001127602-23-000169 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,312 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:02 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 5,473 | $6.28 | $34,370.44 |
DisclosureSEC source: 0001127602-23-000166 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,416 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 21:59 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 1,094 | $6.28 | $6,870.32 |
DisclosureSEC source: 0001127602-23-000165 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,654 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:17 UTC |
Carson SeanaEVP, General Counsel
|
Tax withholdingCommon Shares, No Par Value | 1,691 | $7.70 | $13,020.70 |
DisclosureSEC source: 0001127602-22-026766 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,719 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 20:06 UTC |
Carson SeanaEVP, General Counsel
|
Tax withholdingCommon Shares, No Par Value | 334 | $6.45 | $2,154.30 |
DisclosureSEC source: 0001127602-22-024963 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363,410 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 21:15 UTC Amendment |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 4,989 | $6.89 | $34,374.21 |
DisclosureSEC source: 0001127602-22-023286 · form4a.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,943 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. F2 · shares: This Amended Form 4 is being filed to correct the number of RSUs acquired on September 30, 2022 as reported on the Form 4 filed on October 3, 2022. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 21:15 UTC Amendment |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 9,071 | $6.89 | $62,499.19 |
DisclosureSEC source: 0001127602-22-023292 · form4a.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,338 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. F2 · shares: This Amended Form 4 is being filed to correct the number of RSUs acquired on September 30, 2022 as reported on the Form 4 filed on October 3, 2022. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:49 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 997 | $6.89 | $6,869.33 |
DisclosureSEC source: 0001127602-22-023269 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,560 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:47 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 5,533 | $6.89 | $38,122.37 |
DisclosureSEC source: 0001127602-22-023268 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,487 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:46 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 2,732 | $6.89 | $18,823.48 |
DisclosureSEC source: 0001127602-22-023267 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,999 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:45 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 4,444 | $6.89 | $30,619.16 |
DisclosureSEC source: 0001127602-22-023265 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,723 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:44 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 4,444 | $6.89 | $30,619.16 |
DisclosureSEC source: 0001127602-22-023263 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,601 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:40 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 4,989 | $6.89 | $34,374.21 |
DisclosureSEC source: 0001127602-22-023257 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,579 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 05, 2022 Filed Sep 8, 2022 00:39 UTC |
Vadaketh Tom GeorgeEVP, Chief Financial Officer
|
GrantCommon Shares, No Par Value | 374,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022170 · form4.xml · nonDerivative · entry 1 Vadaketh Tom George · CIK 0001694891 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,514 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 05, 2022 Filed Sep 8, 2022 00:37 UTC |
Carson SeanaEVP, General Counsel
|
GrantCommon Shares, No Par Value | 287,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022168 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363,744 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 05, 2022 Filed Sep 8, 2022 00:33 UTC |
Barresi John SSVP, Controller & CAO
|
GrantCommon Shares, No Par Value | 34,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022166 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,771 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:35 UTC |
APPIO THOMASDirector · Chief Executive Officer
|
Disposition to issuerCommon Shares, No Par Value | 15,389 | $6.59 | $101,413.51 |
DisclosureSEC source: 0001127602-22-022017 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,900 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:02 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 822 | $8.36 | $6,871.92 |
DisclosureSEC source: 0001127602-22-018806 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,563 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 23:28 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 2,251 | $8.36 | $18,818.36 |
DisclosureSEC source: 0001127602-22-018840 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,267 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:04 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 4,560 | $8.36 | $38,121.60 |
DisclosureSEC source: 0001127602-22-018807 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,200 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:00 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 3,663 | $8.36 | $30,622.68 |
DisclosureSEC source: 0001127602-22-018801 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,157 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:01 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 3,663 | $8.36 | $30,622.68 |
DisclosureSEC source: 0001127602-22-018804 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,279 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:59 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 4,111 | $8.36 | $34,367.96 |
DisclosureSEC source: 0001127602-22-018798 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,590 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 6, 2022 20:16 UTC Amendment |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 4,314 | $8.36 | $36,065.04 |
DisclosureSEC source: 0001127602-22-018930 · form4a.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,954 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. F2 · shares: This Amended Form 4 is being filed to correct the number of RSUs acquired on June 30, 2022 as reported on the Form 4 filed on July 5, 2022. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:43 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018205 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,741 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:50 UTC |
POWER ROBERT NDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018208 · form4.xml · nonDerivative · entry 1 POWER ROBERT N · CIK 0001187303 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,811 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:55 UTC |
KAVANAGH SARAH BDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018211 · form4.xml · nonDerivative · entry 1 KAVANAGH SARAH B · CIK 0001681171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,447 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:52 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018210 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,616 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:51 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018209 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,016 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:47 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018207 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,640 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:45 UTC |
Ross Thomas W. Sr.Director
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018206 · form4.xml · nonDerivative · entry 1 Ross Thomas W. Sr. · CIK 0001669396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,311 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:42 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018204 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,494 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:40 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018203 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,479 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:38 UTC |
KARABELAS ARGERIS NDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018201 · form4.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,715 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:35 UTC |
Mulligan RichardDirector
|
GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018200 · form4.xml · nonDerivative · entry 1 Mulligan Richard · CIK 0001376247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,704 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| June 20, 2022 Filed Jun 22, 2022 22:30 UTC |
Barresi John SSVP, Controller & CAO
|
GrantCommon Shares, No Par Value | 16,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017993 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,898 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 13, 2022 Filed May 17, 2022 22:04 UTC |
Mulligan RichardDirector
|
GrantCommon Shares, No Par Value | 2,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-014807 · form4.xml · nonDerivative · entry 1 Mulligan Richard · CIK 0001376247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,317 F1 · shares: Represents Restricted Share Units ("RSUs"), each representing a contingent right to receive one Common Share, no par value, of Bausch Health Companies Inc., which will vest immediately before the 2022 Annual Meeting of Shareholders. Read SEC document |
| May 10, 2022 Filed May 13, 2022 01:18 UTC |
Carson SeanaEVP, General Counsel
|
Exercise / conversionRestricted Share Units · Derivative | 4,715 | $9.40 | $44,321.00 |
DisclosureSEC source: 0000899243-22-017890 · doc4.xml · derivative · entry 6 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 0 shares Expires 2022-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F2 · shares: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. F2 · derivative.exercise_date: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.